Back To Schedule
Tuesday, June 20 • 10:30am - 11:30am
#217: Update from CBER: Advancing the Development of Complex Biologic Products

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: CME 1.00; IACET 1.00; RN 1.00

This session will provide an overview of how the Center for Biologics Evaluation and Research (CBER) works to advance the development of complex biological products such as vaccines, live biotherapeutics, and cellular and gene therapies. The session will include a discussion of how the Center is working to implement relevant provision of the 21st Century Cure Act aimed at further expediting the development of important medical products.

Learning Objectives

Identify regulatory work recently completed or in progress and communicate Center priorities for the coming years.


Peter W. Marks, MD, PhD

avatar for Peter Marks

Peter Marks

Director, Center for Biologics Evaluation and Research, FDA, United States
Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching... Read More →

Tuesday June 20, 2017 10:30am - 11:30am CDT
S404a McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  05: Regulatory, Forum
  • Level Intermediate
  • format json
  • Featured Topics StudentProgramming,Global Regulatory
  • Credit Type CME, IACET, RN
  • Tags Forum